Esperion misses revenue estimate. Another lackluster net revenue. 66 million in net losses.



















Well folks, the stock is only up about 20% year to date, and the floor is in. Look for some fairly pronounced activity over the next six weeks you’re gonna see a push to seven.Big Pharma has been punished recently due to the pending legislation, and now that that appears to be resolved in a somewhat favorable manner you’ll see some strong price action.

What is this nonsense. The money burn continues. Lack of growth is apparent. This one will need a life line soon.
 












How has the plug not been pulled on this show. Didn't start out good and has only got worse. What is there now like 16 reps now? They hired a big number at the start. What happened and how did this fall of the rails so fast?